Vitrolife AB (publ) (STO:VITR)
Sweden · Delayed Price · Currency is SEK 89.35
-1.75 (-1.92%)
Jul 6, 2026, 5:29 PM CET
Vitrolife AB Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Vitrolife AB stock has a consensus rating of "Buy" and an average price target of kr 132.20. The average 1-year stock price forecast is 47.96% higher than the current stock price, while the lowest is kr 95.00 (+6.32%) and the highest is kr 155.00 (+73.48%).
Price Target: kr 132.20 (+47.96%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Vitrolife AB stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 3 | 3 |
| Buy | 0 | 0 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 5 | 4 | 4 |
Financial Forecast
Revenue This Year
3.50B
from 3.44B
Increased by 1.78%
Revenue Next Year
3.78B
from 3.50B
Increased by 7.85%
EPS This Year
3.97
from 2.89
Increased by 37.26%
EPS Next Year
4.75
from 3.97
Increased by 19.83%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.5B | ||
| Avg | 3.5B | ||
| Low | 3.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.1% | ||
| Avg | 1.8% | ||
| Low | 0.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.86 | ||
| Avg | 3.97 | ||
| Low | 3.39 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 68.2% | ||
| Avg | 37.3% | ||
| Low | 17.3% |